Deucravacitinib, a TYK2 inhibitor, safety in psoriasis and psoriatic arthritis: What should a dermatologist know?

• Inês Pereira Amaral,
• Joana Antunes,
• Ivânia Soares,
• Madalena Pupo Correia,
• Paulo Filipe

Affiliations

Inês Pereira Amaral

Dermatology Department Centro Hospitalar Universitário Lisboa Norte EPE Lisbon Portugal

Joana Antunes

Dermatology Department Centro Hospitalar Universitário Lisboa Norte EPE Lisbon Portugal

Ivânia Soares

Dermatology Department Centro Hospitalar Universitário Lisboa Norte EPE Lisbon Portugal

Madalena Pupo Correia

Dermatology Department Centro Hospitalar Universitário Lisboa Norte EPE Lisbon Portugal

Paulo Filipe

Dermatology Department Centro Hospitalar Universitário Lisboa Norte EPE Lisbon Portugal